QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer (COMPASS)
Comparison of Quality of Life (QoL) Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Peritoneal Cancer
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Terminated
A total of 204 patients were planned to be randomized. Due to slow recruitment of the trial, the recruitment was prematurely terminated after randomization of the 89th patient.
Other terminated trials from Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Cholangiocarcinoma · Jun 2025
- Soft Tissue Sarcoma · Jul 2024
- Solid Tumor · Jan 2023
- Advanced Renal Cell Carcinoma (All Subtypes) · Feb 2021
- Advanced Soft Tissue Sarcoma · Phase PHASE2 · Jun 2020
See all terminations from Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
A PHASE4 clinical study on Ovarian Cancer and Quality of Life, this trial is terminated or withdrawn. The trial is conducted by Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest and has accumulated 17 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Apr 2025 — Sep 2025 [monthly]
Terminated PHASE4
Status: Completed → Terminated
-
Sep 2024 — Apr 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 12 earlier versions
-
May 2022 — Dec 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — May 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE4
-
Aug 2020 — Oct 2020 [monthly]
Recruiting PHASE4
Phase: None → PHASE4
-
Jan 2020 — Aug 2020 [monthly]
Recruiting
-
Jul 2018 — Jan 2020 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting · Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Not Yet Recruiting → Active Not Recruiting
-
Jun 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- North Eastern German Society of Gynaecological Oncology
- PharmaMar
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Berlin, Germany , Bonn, Germany , Brandenburg, Germany , Braunschweig, Germany , Dessau, Germany , Dresden, Germany , Frankfurt, Germany , Freiburg im Breisgau, Germany , Krefeld, Germany and 8 more locations